Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2)
Phase 2
- Conditions
- Tuberculosis Identification.
- Interventions
- Biological: To compare new PPD to reference standard materialBiological: Reference standard
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 90
- Registration Number
- NCT01798121
Equivalence Study of Specificity of PPD
Phase 2
- Conditions
- Tuberculosis Infection
- Interventions
- Biological: Aplisol@ PPD materialBiological: Reference Standard
- First Posted Date
- 2013-02-25
- Last Posted Date
- 2013-02-25
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 152
- Registration Number
- NCT01798095
- Locations
- 🇺🇸
The University of Texas Health Science Center at Tyler, Tyler, Texas, United States
Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)
Phase 2
- Conditions
- Tuberculosis Infection
- Interventions
- Biological: To confirm the potency of Aplisol formulated with newly produced Tuberculin PPD compared to PPD-S2 standard.Biological: Reactivity of Aplisol compared to reference standard PPD-S2.
- First Posted Date
- 2012-09-21
- Last Posted Date
- 2012-09-21
- Lead Sponsor
- JHP Pharmaceuticals LLC
- Target Recruit Count
- 168
- Registration Number
- NCT01689831
- Locations
- 🇺🇸
The University of Texas Health Science Center at Tyler, Tyler, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath